country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-184266

Copy Link Print Information

GCLCi0

(Synonyms: ONO-6428513)

GCLCi0 (ONO-6428513) is a glutamate-cysteine ligase catalytic subunit (GCLC) inhibitor and ferroptosis inducer that blocks the rate-limiting step of glutathione synthesis and exerts anti-tumor activity. GCLCi0 specifically targets SMARCB1-deficient cancer cells, induces reactive oxygen species production and lipid peroxidation. In addition, GCLCi0 shows a significant synergistic effect with SLC7A11 inhibitors and Telaglenastat (HY-12248). GCLCi0 can be used in the research of smarcb1-deficient malignant rhabdoid tumors and smarcb1-deficient epithelioid sarcomas.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No.: 2926699-71-8
화학식: C₈H₁₅F₃N₂O₃S
분자량:276.28

보관:

Please store the product under the recommended conditions in the Certificate of Analysis.

GCLCi0 Chemical Structure

CAS No.: 2926699-71-8

사이즈

가격

재고

수량

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- In Vitro
Chemical Information
순도&문서
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

In Vitro

GCLCi0 (72 h) potently and selectively inhibits the viability of SMARCB1-deficient rhabdoid tumor cells (JMU-RTK-2, G401, G402) with significantly lower IC₅₀ values than in SMARCB1-proficient renal cancer cells, displaying a selective index superior to approved EZH2 inhibitors^[1].
GCLCi0 (0.1-10 μM; 24-48 h) selectively depletes the GSH/GSSG ratio in SMARCB1-deficient rhabdoid tumor cells (JMU-RTK-2, G401, G402) in a concentration-dependent manner, with minimal effect on SMARCB1-proficient renal cancer cells^[1].
GCLCi0 (0.1-4 μM; 72 h) selectively induces concentration-dependent lipid peroxidation in SMARCB1-deficient rhabdoid tumor cells (JMU-RTK-2, G401), an effect that is suppressed by the ferroptosis inhibitor Ferrostatin-1 (HY-100579)^[1].
GCLCi0 (72 h) antiproliferative effect on SMARCB1-deficient JMU-RTK-2 rhabdoid tumor cells is rescued by the ferroptosis inhibitor ferrostatin-1 but not by the apoptosis inhibitor Z-VAD-FMK, confirming ferroptosis as the mechanism of cell death^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

CAS No. 2926699-71-8
분자량 276.28
화학식 C₈H₁₅F₃N₂O₃S
SMILES

N[C@H](C(O)=O)CCS(=N)(CCCC(F)(F)F)=O
Synonyms

ONO-6428513
선적

Room temperature in continental US; may vary elsewhere.
보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Handling Instructions (2659 KB)

References

[1]. Takeuchi M, et al.. A GCLC Inhibitor Enhances the Antitumor Efficacy of Glutathione Metabolic Pathway Inhibition in SMARCB1-Deficient Rhabdoid Tumors. Cancer research. 2026 Jun 15;86(12):2990-3004. [Content Brief]

Calculators

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

100 mg

견적 받기 해외재고보유